ADHANSIA XR Trademark

Trademark Overview

On Tuesday, January 16, 2018, a trademark application was filed for ADHANSIA XR with the United States Patent and Trademark Office. The USPTO has given the ADHANSIA XR trademark a serial number of 87982478. The federal status of this trademark filing is REGISTERED as of Tuesday, January 28, 2020. This trademark is owned by Purdue Pharma. The ADHANSIA XR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, and executive functioning disorder
adhansia xr

General Information

Serial Number87982478
Word MarkADHANSIA XR
Filing DateTuesday, January 16, 2018
Status700 - REGISTERED
Status DateTuesday, January 28, 2020
Registration Number5973730
Registration DateTuesday, January 28, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 28, 2018

Trademark Statements

Disclaimer with Predetermined Text"XR"
Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, and executive functioning disorder

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, January 28, 2018
Primary Code005
First Use Anywhere DateThursday, July 11, 2019
First Use In Commerce DateThursday, July 11, 2019

Trademark Owner History

Party NamePURDUE PHARMA L.P.
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressSTAMFORD, CT 06901
Party NamePURDUE PHARMA L.P.
Party Type21 - New Owner After Publication
Legal Entity Type13 - Limited Partnership
AddressSTAMFORD, CT 06901
Party NamePurdue Pharma
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressPickering, Ontario L1W3W8
CA
Party NamePurdue Pharma
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressPickering, Ontario L1W3W8
CA

Trademark Events

Event DateEvent Description
Tuesday, January 28, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, December 21, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, December 20, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 18, 2019DIVISIONAL PROCESSING COMPLETE
Wednesday, December 11, 2019DIVISIONAL REQUEST RECEIVED
Wednesday, December 11, 2019TEAS REQUEST TO DIVIDE RECEIVED
Friday, September 27, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 27, 2019NON-FINAL ACTION E-MAILED
Friday, September 27, 2019SU - NON-FINAL ACTION - WRITTEN
Friday, September 20, 2019STATEMENT OF USE PROCESSING COMPLETE
Friday, August 23, 2019USE AMENDMENT FILED
Wednesday, September 18, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 23, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, February 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 25, 2019EXTENSION 1 GRANTED
Monday, February 25, 2019EXTENSION 1 FILED
Monday, February 25, 2019TEAS EXTENSION RECEIVED
Wednesday, February 20, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 13, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 13, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 23, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 28, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 28, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 8, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 18, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 10, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 9, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 9, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 29, 2018TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 26, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 26, 2018NON-FINAL ACTION E-MAILED
Thursday, April 26, 2018NON-FINAL ACTION WRITTEN
Thursday, April 26, 2018ASSIGNED TO EXAMINER
Sunday, January 28, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 19, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

adhansia disorder pharmaceutical attention deficit nervous hyperactivity system treatment preparations central